What Researchers Did
The researchers described one woman with a history of multiple myeloma who developed spinal cord problems after radiation therapy, and they reported how her condition was treated with steroids and then with intravenous immune globulin (IVIG).
What They Found
This single case report describes a 55-year-old woman whose delayed radiation myelitis, which began 11 months after radiation therapy, was treated with methylprednisolone and then IVIG, with her neurological symptoms resolving and a scan lesion enhancement resolving. Methylprednisolone pulse therapy led to complete resolution of her neurological symptoms. At follow-up she had no new neurological complications, but MRI still showed residual enhancement in the thoracic spinal cord. Because of the possibility that the myelitis could progress and the spinal cord could shrink, IVIG was given, and the enhancement then resolved. The authors suggest IVIG could be regarded as a potential therapeutic option when delayed radiation myelopathy is active.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This is a report of a single patient with no comparison group, so it cannot show that IVIG caused the MRI improvement, and the lesion may have changed for other reasons, including the earlier steroid treatment.